Part B Drug Payment Change: Understanding the Implications for Pharma

By Amanda Forys, MSPH |

Amanda Forys and Jennifer Snow recorded a live webinar on March 28, 2016 and provided insights on the Part B Drug Payment Model. They focused on what’s known about the proposed Medicare Part B drug payment model and what the implications are for pharmaceutical manufacturers. Ms. Forys and Ms. Snow also shared strategies on how manufacturers will have to evolve to demonstrate product value.

About the Authors

Amanda Forys, MSPH

Senior Director, Reimbursement Policy & Insights
View Bio

Jennifer Snow, MPH

Senior Director, Policy Insights
View Bio